Thought leadership
Microbial cell-free DNA testing can help identify difficult infections when conventional diagnostics fall short.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.
Strategic Lab Collaborations help Mayo Clinic Laboratories accelerate innovation and expand access to advanced diagnostics.
Dr. Chris Garcia discusses how diagnostics, data integration, and early laboratory engagement can improve clinical trial participation.
Mary Jo Williamson shares how trust, curiosity, transparency, and a strong mission help organizations build change-ready, future-focused cultures.
From personalized medicine to AI, discover how current trends are shaping the future of diagnostics and patient care.
Leveraging the Laboratory 2026 highlighted how labs can drive growth by embracing innovation, investing in people, and advocating for their value.
In a Becker’s Healthcare podcast, Dr. Bill Morice discusses precision medicine, AI, patient expectations, and challenges facing laboratories.
Christopher Garcia, M.D., on why a new generation of therapies puts laboratory medicine at the center of care, and how data and AI can help make sure patients never wait on the diagnostic.
Specialized immunofluorescence testing helps uncover rare autoimmune blistering diseases, identify underlying cancers, and guide precise treatment, improving diagnostic accuracy and outcomes for patients with challenging skin disorders.
Discover in a Becker’s Healthcare podcast how leaders can help teams navigate rapid change while staying grounded in mission, strategy, and values.
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss Protecting Access to Medicare Act (PAMA) reform and recent reports about the New World screwworm. Dr. Morice also shares insights on building an innovation strategy that delivers meaningful organizational value.
Genome-wide methylation profiling is transforming the way clinicians approach brain tumor diagnosis. By analyzing epigenetic patterns across the genome, this advanced testing method provides a new level of precision, helping resolve ambiguous cases, reduce diagnostic variability, and support more confident clinical decision-making in complex CNS tumors.